Polymorphism, Restriction Fragment Length Clinical Trial
Official title:
The Effect of an Acute Maximal Exercise on Serum Uncoupling Protein-1 Level and the Role of Uncoupling Protein-1-3826 A/G Polymorphism
This study aims to determine the effect of an acute maximal exercise on serum uncoupling
protein-1, irisin, interleukin 6 levels, and on blood lipid and lipoprotein concentrations.
This study also evaluates the role of uncoupling protein-1-3826 A/G polymorphism on this
eventual effect.
Therefore, this study hypothesizes that:
H01: Sedentary people and athletes' serum uncoupling protein 1, irisin, and interleukine 6
levels are different before and after an acute maximal exercise.
H02: Sedentary people and athletes' basal serum uncoupling protein 1 levels are associated
with uncoupling protein 1-3826 A/G polymorphism.
H03: Uncoupling protein 1-3826 A/G polymorphism has a modifying role in the effect of maximal
exercise on serum uncoupling protein 1 levels.
H04: Sedentary people and athletes' basal serum lipid and lipoprotein levels are associated
with uncoupling protein 1-3826 A/G polymorphism.
H05: Uncoupling protein 1-3826 A / G polymorphism has a modifying role in the effect of
maximal exercise on serum lipid and lipoprotein levels.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04298346 -
Neurological Fate, Prematurity and Genetic Susceptibility Factors
|
||
| Completed |
NCT04806971 -
Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene Polymorphisms in Periodontitis
|
||
| Completed |
NCT04077554 -
Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk Factors
|
||
| Recruiting |
NCT05750732 -
Weight Loss and CLOCK 3111T/C Polymorphism
|